Does EVEROLIMUS Cause Skin atrophy? 20 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Skin atrophy have been filed in association with EVEROLIMUS (EVEROLIMUS). This represents 0.1% of all adverse event reports for EVEROLIMUS.
20
Reports of Skin atrophy with EVEROLIMUS
0.1%
of all EVEROLIMUS reports
0
Deaths
5
Hospitalizations
How Dangerous Is Skin atrophy From EVEROLIMUS?
Of the 20 reports, 5 (25.0%) required hospitalization, and 1 (5.0%) were considered life-threatening.
Is Skin atrophy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVEROLIMUS. However, 20 reports have been filed with the FAERS database.
What Other Side Effects Does EVEROLIMUS Cause?
Death (5,090)
Malignant neoplasm progression (3,789)
Diarrhoea (3,061)
Fatigue (2,946)
Stomatitis (2,692)
Nausea (2,079)
Dyspnoea (1,925)
Drug ineffective (1,837)
Pyrexia (1,664)
Decreased appetite (1,633)
What Other Drugs Cause Skin atrophy?
DUPILUMAB (262)
PREDNISONE (258)
ADALIMUMAB (205)
METHOTREXATE (191)
ETANERCEPT (139)
CLOBETASOL (123)
SECUKINUMAB (121)
IBRUTINIB (112)
TRIAMCINOLONE ACETONIDE (110)
HYDROCORTISONE (106)
Which EVEROLIMUS Alternatives Have Lower Skin atrophy Risk?
EVEROLIMUS vs EVOLOCUMAB
EVEROLIMUS vs EXELON
EVEROLIMUS vs EXEMESTANE
EVEROLIMUS vs EXENATIDE
EVEROLIMUS vs EXFORGE